Search Results - "Victoria, Ivan"

Refine Results
  1. 1

    Testing Physical Scenarios for the Reflection Features of Type-1 AGNs using XMM-Newton and NuSTAR Simultaneous Observations by Victoria-Ceballos, César Ivan, González-Martín, Omaira, Masegosa, Josefa, Longinotti, Anna Lia, Esparza-Arredondo, Donaji, Osorio-Clavijo, Natalia

    Published in The Astrophysical journal (01-09-2023)
    “…Above ∼3 keV, the X-ray spectrum of active galactic nuclei (AGNs) is characterized by the intrinsic continuum and Compton reflection features. For type-1 AGNs,…”
    Get full text
    Journal Article
  2. 2

    AGN Torus Detectability at Submillimeter Wavelengths: What to Expect from ALMA Continuum Data by Pasetto, Alice, González-Martín, Omaira, Esparza-Arredondo, Donaji, Osorio-Clavijo, Natalia, Victoria-Ceballos, César Ivan, Martínez-Paredes, Mariela

    Published in The Astrophysical journal (10-02-2019)
    “…Dust close (∼few pc) to the accretion disk in active galactic nuclei (AGNs) is key to understanding many of their observational signatures, and it is key to…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Motor polyradiculopathy during pembrolizumab treatment of metastatic melanoma by Sepúlveda, Maria, Martinez‐Hernandez, Eugenia, Gaba, Lydia, Victoria, Ivan, Sola‐Valls, Nuria, Falgàs, Neus, Casanova‐Molla, Jordi, Graus, Francesc

    Published in Muscle & nerve (01-12-2017)
    “…ABSTRACT Introduction Pembrolizumab, a monoclonal antibody directed against the immune checkpoint programmed cell death‐1 receptor (PD‐1), has improved…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12

    Glutamine and Cholesterol Plasma Levels and Clinical Outcomes of Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Taxanes by Marín-Aguilera, Mercedes, Pereira, María V., Jiménez, Natalia, Reig, Òscar, Cuartero, Anna, Victoria, Iván, Aversa, Caterina, Ferrer-Mileo, Laura, Prat, Aleix, Mellado, Begoña

    Published in Cancers (01-10-2021)
    “…Altered metabolism is a hallmark of cancer. Malignant cells metabolise glutamine to fulfil their metabolic needs. In prostate cancer, androgen receptor…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Ipilimumab after progression on anti-PD-1 treatment in advanced melanoma by Aya, Francisco, Gaba, Lydia, Victoria, Iván, Fernández-Martínez, Aranzazu, Tosca, Mónica, Prat, Aleix, Arance, Ana

    Published in Future oncology (London, England) (01-12-2016)
    “…While both efficacy and safety of anti-PD-1 agents seem to be independent of previous treatment with anti-CTLA-4, limited data exist of efficacy and toxicity…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19

    Pembrolizumab in a BRAF-mutant metastatic melanoma patient following a severe immune-related adverse event with ipilimumab by Aya, Francisco, Fernández-Martínez, Aranzazu, Gaba, Lydia, Victoria, Iván, Tosca, Mónica, Carrera, Cristina, Prat, Aleix, Arance, Ana

    Published in Immunotherapy (01-06-2016)
    “…Currently, limited data exist on the safety of pembrolizumab in patients with metastatic melanoma who have developed severe immune-related adverse events…”
    Get full text
    Journal Article
  20. 20